je.st
news
Sevion Therapeutics Announces Chimerasome Research Agreement
2014-12-03 07:07:57| drugdiscoveryonline News Articles
Sevion Therapeutics, a biopharmaceutical company which discovers, develops and acquires next-generation biologics for the treatment of cancer and immunological diseases, recently announced that it has entered into a research agreement with Avidity NanoMedicines LLC related to the use of Sevion’s chimerasome technology for delivery of nucleic acids
Tags: research
agreement
announces
therapeutics
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||